참고문헌
- Hahn SY, Kim TH, Ki CS, Kim SW, Ahn S, Shin JH, et al. Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations. Oncotarget 2017;8:108946-108957 https://doi.org/10.18632/oncotarget.22430
- Kim TH, Kim YE, Ahn S, Kim JY, Ki CS, Oh YL, et al. TERT promoter mutations and long-term survival in patients with thyroid cancer. Endocr Relat Cancer 2016;23:813-823 https://doi.org/10.1530/ERC-16-0219
- Liu C, Liu Z, Chen T, Zeng W, Guo Y, Huang T. TERT promoter mutation and its association with clinicopathological features and prognosis of papillary thyroid cancer: a meta-analysis. Sci Rep 2016;6:36990
- Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab 2014;99:E754-E765 https://doi.org/10.1210/jc.2013-3734
- Kim SY, Kwak JY, Kim EK, Yoon JH, Moon HJ. Association of preoperative US features and recurrence in patients with classic papillary thyroid carcinoma. Radiology 2015;277:574-583 https://doi.org/10.1148/radiol.2015142470
- Rhee SJ, Hahn SY, Ko ES, Ryu JW, Ko EY, Shin JH. Follicular variant of papillary thyroid carcinoma: distinct biologic behavior based on ultrasonographic features. Thyroid 2014;24:683-688 https://doi.org/10.1089/thy.2013.0351
- Nam SY, Shin JH, Han BK, Ko EY, Ko ES, Hahn SY, et al. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior. J Clin Endocrinol Metab 2013;98:1476-1482 https://doi.org/10.1210/jc.2012-4072
- D'Avanzo A, Ituarte P, Treseler P, Kebebew E, Wu J, Wong M, et al. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 2004;14:453-458 https://doi.org/10.1089/105072504323150778
- Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003;88:5399-5404 https://doi.org/10.1210/jc.2003-030838
- Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol 2009;20:1728-1735 https://doi.org/10.1093/annonc/mdp050
- Pennelli G, Vianello F, Barollo S, Pezzani R, Merante Boschin I, Pelizzo MR, et al. BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. Thyroid 2011;21:1393-1396 https://doi.org/10.1089/thy.2011.0120
- Vogrin A, Besic H, Besic N, Music MM. Recurrence rate in regional lymph nodes in 737 patients with follicular or Hurthle cell neoplasms. Radiol Oncol 2016;50:269-273 https://doi.org/10.1515/raon-2016-0025
- Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. J Am Soc Cytopathol 2017;6:217-222 https://doi.org/10.1016/j.jasc.2017.09.002
- Kakudo K, Bychkov A, Bai Y, Li Y, Liu Z, Jung CK. The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives. Pathol Int 2018;68:641-664 https://doi.org/10.1111/pin.12737
- Lloyd R, Osamura R, Kloppel G, Rosai J. WHO classification of tumours of endocrine organs. 4th ed. Lyon: IARC Press, 2017:65-91
- Jin M, Kim ES, Kim BH, Kim HK, Yi HS, Jeon MJ, et al. Clinical implication of World Health Organization classification in patients with follicular thyroid carcinoma in South Korea: a multicenter cohort study. Endocrinol Metab (Seoul) 2020;35:618-627 https://doi.org/10.3803/EnM.2020.742
- Park H, Shin HC, Yang H, Heo J, Ki CS, Kim HS, et al. Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations. Mod Pathol 2022;35:186-192 https://doi.org/10.1038/s41379-021-00907-6
- Kabaker AS, Tublin ME, Nikiforov YE, Armstrong MJ, Hodak SP, Stang MT, et al. Suspicious ultrasound characteristics predict BRAF V600E-positive papillary thyroid carcinoma. Thyroid 2012;22:585-589 https://doi.org/10.1089/thy.2011.0274
- Zhang Q, Liu BJ, Ren WW, He YP, Li XL, Zhao CK, et al. Association between BRAF V600E mutation and ultrasound features in papillary thyroid carcinoma patients with and without Hashimoto's thyroiditis. Sci Rep 2017;7:4899
- Kim TH, Ki CS, Hahn SY, Oh YL, Jang HW, Kim SW, et al. Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer. Endocrine 2017;57:234-240 https://doi.org/10.1007/s12020-017-1340-3
- Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science 2013;339:957-959 https://doi.org/10.1126/science.1229259
- Sohn SY, Park WY, Shin HT, Bae JS, Ki CS, Oh YL, et al. Highly concordant key genetic alterations in primary tumors and matched distant metastases in differentiated thyroid cancer. Thyroid 2016;26:672-682 https://doi.org/10.1089/thy.2015.0527
- Ha EJ, Chung SR, Na DG, Ahn HS, Chung J, Lee JY, et al. 2021 Korean thyroid imaging reporting and data system and imaging-based management of thyroid nodules: Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol 2021;22:2094-2123 https://doi.org/10.3348/kjr.2021.0713
- Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol 2017;14:587-595 https://doi.org/10.1016/j.jacr.2017.01.046
- Siebert SM, Gomez AJ, Liang T, Tahvildari AM, Desser TS, Jeffrey RB, et al. Diagnostic performance of margin features in thyroid nodules in prediction of malignancy. AJR Am J Roentgenol 2018;210:860-865 https://doi.org/10.2214/AJR.17.18787
- Haug LP, Dahiya N, Young SW, Patel MD. Thyroid nodule margin assessment using ACR TI-RADS: adding points for macrolobulation impairs performance. J Ultrasound Med 2023;42:409-415 https://doi.org/10.1002/jum.16034
- Liu BJ, Zhang YF, Zhao CK, Wang HX, Li MX, Xu HX. Conventional ultrasound characteristics, TI-RADS category and shear wave speed measurement between follicular adenoma and follicular thyroid carcinoma. Clin Hemorheol Microcirc 2020;75:291-301 https://doi.org/10.3233/CH-190750
- Ryu J, Lee K, Kim H, Eun C, Kim O, Yoon J, et al. Follicular thyroid carcinoma with predominantly cystic formation presenting initially with multiple distant metastases. J Med Ultrason (2001) 2014;41:233-237 https://doi.org/10.1007/s10396-013-0478-8
- Lai X, Jiang Y, Zhang B, Liang Z, Jiang Y, Li J, et al. Preoperative sonographic features of follicular thyroid carcinoma predict biological behavior: a retrospective study. Medicine (Baltimore) 2018;97:e12814
- Zhang JZ, Hu B. Sonographic features of thyroid follicular carcinoma in comparison with thyroid follicular adenoma. J Ultrasound Med 2014;33:221-227 https://doi.org/10.7863/ultra.33.2.221
- Seo HS, Lee DH, Park SH, Min HS, Na DG. Thyroid follicular neoplasms: can sonography distinguish between adenomas and carcinomas? J Clin Ultrasound 2009;37:493-500 https://doi.org/10.1002/jcu.20625
- Li W, Song Q, Lan Y, Li J, Zhang Y, Yan L, et al. The value of sonography in distinguishing follicular thyroid carcinoma from adenoma. Cancer Manag Res 2021;13:3991-4002 https://doi.org/10.2147/CMAR.S307166
- Park KW, Shin JH, Hahn SY, Oh YL, Kim SW, Kim TH, et al. Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma? Clin Endocrinol (Oxf) 2020;92:468-474 https://doi.org/10.1111/cen.14167
- Shin JH, Han BK, Ko EY, Oh YL, Kim JH. Differentiation of widely invasive and minimally invasive follicular thyroid carcinoma with sonography. Eur J Radiol 2010;74:453-457 https://doi.org/10.1016/j.ejrad.2009.03.019
- Yang J, Gong Y, Yan S, Chen H, Qin S, Gong R. Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis. Endocrine 2020;67:44-57 https://doi.org/10.1007/s12020-019-02117-2
- Song YS, Lim JA, Min HS, Kim MJ, Choi HS, Cho SW, et al. Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer. Eur J Endocrinol 2017;177:465-473 https://doi.org/10.1530/EJE-17-0456
- Paulsson JO, Mu N, Shabo I, Wang N, Zedenius J, Larsson C, et al. TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours. Endocr Relat Cancer 2018;25:723-733 https://doi.org/10.1530/ERC-18-0050
- Shi H, Guo LH, Zhang YF, Fu HJ, Zheng JY, Wang HX, et al. Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter. Endocrine 2020;68:349-357 https://doi.org/10.1007/s12020-020-02214-7